RJFSA
RVMD icon

Raymond James Financial Services Advisors’s Revolution Medicines RVMD Stock Holding History

Raymond James Financial Services Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.62M Buy
+35,730
New +$1.56M ﹤0.01% 1859
2020
Q4 		– Sell
-24,152
Closed -$840K – 3066
2020
Q3 		$840K Buy
+24,152
New +$669K ﹤0.01% 1658

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Raymond James Financial Services Advisors's RVMD Position: Q3 2024 in Review

Raymond James Financial Services Advisors opened a new position in Revolution Medicines (RVMD) in Q3 2024: 35,730 shares worth $1.62M. The stake represents ﹤0.01% of the portfolio and ranks #1859 among its holdings. This is a return to the name: Raymond James Financial Services Advisors previously reported a position in RVMD as recently as Q3 2020.

Raymond James Financial Services Advisors first reported a position in RVMD in Q3 2020 and has held it in 2 quarters since. 255 funds tracked by Wall St. Rank hold RVMD as of Q3 2024.

  • Raymond James Financial Services Advisors held 35,730 shares of Revolution Medicines worth $1.62M as of Q3 2024.
  • Revolution Medicines was a new Raymond James Financial Services Advisors position in Q3 2024.
  • Revolution Medicines made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #1859 holding.
  • Raymond James Financial Services Advisors first reported a position in Revolution Medicines in Q3 2020 and has held it in 2 quarters since.
  • 255 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.